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Exposure ofnmce to 1000 ppm ofvinyl chloride (VC), 6 hr/day, 5 days/week, caused some acute deaths
with toxic hepatitis and marked tubular necrosis of the renal cortex. Starting the sixth month, mice
exposed to 1000, 250, or 50 ppm ofVC became lethargic, lost weightquickly, and died. Only a few mice
exposed to 50 ppm survived for 12 months. Pulmonary macrophage count was elevated in some mice.
There was a high incidence ofbronchiolo-alveolar adenoma, mammary gland tumors including ductular
adenocarcinoma, squ and ic cell carcinomas with metastasis to the lung, and heman-
glosarcoma in the liver, and, to a leser extent, in some other organs. The incidence of these tumors
quickly increased, and theseverity was indirect proportion to the levelsofVC and thelengthofexposure.
Malignant lymphoma involving various organs was observed in a few mice.
Rats were more resistant to the toxic effects ofVC. Exposure to 1000 ppm slightly depressed the body
weightofthe females. Exposures of250 or 1000ppm caused anumber ofdeathsand hemangiosarcoma in
the liver starting the ninth month. Most rats with hepatic hemangiosarcoma also developed hemangiosar-
coma in the lung. Hemangiosarcoma occasionally occurred in other tissues ofone or two rats exposed to
50 ppm or higher level of VC.
Exposure of mice to 55 ppm of vinylidene chloride (VDC) also caused a few acute deaths and a few
hepatic hemanglosarcomas. Inflammatory, degenerative, and mitotic changes occurred in the liver. No
mouse exposed to VDC developed any mammary gland tumors. Several mice had bronchioloalveolar
adenoma. Exposure of rats to 55 ppm of VDC slightly depressed the body weight. Hemanglosarcoma
occurred in the mesenteric lymph node or subcutaneous tissue in two rats.
Introduction
Vinyl chloride (VC) was first prepared more than
a century ago, and its fire and explosion hazards are
well known. Acute toxicity of VC was first re-
ported in guinea pigs (1). As a possible anesthetic
agent in dogs, VC was found to cause incoordinated
muscular activity of the extremities, cardiac ar-
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rhythmias (2), and sensitization ofthe myocardium
(3). Relatively high concentrations of VC (1040o
in air) for 30 min produced narcosis and/or death in
mice, rats, and guinea pigs (4). The guinea pigs
were found to be more resistant. The main lesions
were congestion of the lung with pulmonary edema
and hemorrhages in some animals, and congestion
of the liver and kidney. Failure ofthe blood to clot
was also observed. Detectable injury of the liver
and/or kidney occurred in rats exposed to 100, 250,
or 500 ppm but not 50 ppm of VC, 7 hr/day and 5
days/week, for up to 6 months (5). Changes in liver
and spleen weights, a decrease in leukocytes, and
an increase in erythrocytes were observed in rats
exposed to 2% VC, 8 hr/day for 3 months (6).
Carcinogenic action of VC was first reported in
1971. Male rats (Ar/IRE) exposed to 30,000 ppm of
VC, 4 hr/day and 5 days/week for 12 months, de-
veloped tumors of the skin, lungs, and bones (7).
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blastoma, hepatic and extrahepatic angiosarcomas
were observed in rats and pulmonary tumors,
mammary carcinomas, and liver angiosarcomas
were observed in mice exposed to as low as 50 ppm
of VC, 4 hr/day, 5 days/week, after 7-12 months
(8). Angiosarcoma of the liver and other hepatic
diseases, notably portal fibrosis, were identified
among VC polymerization workers (9-12). An
epidemiological study (13) indicated that cancers at
multiple sites might be developed in VC and
poly(vinyl chloride) workers.
The present study was undertaken to determine
the toxic and carcinogenic effects of50, 250, or 1000
ppm of VC in rats and mice and to define any possi-
ble biochemical changes relating to any histological
and neoplastic lesions. In addition, one extra
chamber was available and used to compare the ef-
fects of 55 ppm of vinylidene chloride (VDC).
Material and Methods
Inhalation Chambers and Monitoring
The inhalation chambers are cubical type and
made of stainless steel, with a volume of 3.5 m3.
Three chambers were used for 50, 250, or 1000 ppm
of VC; one chamber was used for 55 ppm of VDC,
and one chamber was used for uncontaminated
air as control. VC gas (99.8% pure, Matheson
Products) was metered with rotameters into the
chamber air supply. VDC (99% pure, Aldrich
Company) was heated to 37°C to generate the
vapor. The VDC lines and rotameter were heated
to 40°C to prevent condensation. Chamber air was
initially sampled with a syringe and monitored using
a gas chromatograph (Varian-2700) with a flame
ionization detector. An automatic sampling system
was later used. Periodically, a sample was directed
to the gas chromatograph and the readout was pro-
cessed by a Varian CDS II1 electronic integrator.
The integrator was programmed to measure peak
area and to calculate chamber concentrations by
external standards.
Experimental Design
Albino CD-1 mice and CD rats (Charles River
Breeding Lab) about 2 months old were used at the
start in these studies. For each species, 360 animals
were divided into five groups, each consisting of36
males and 36 females. Each group of both species
was exposed to 50, 250, or 1000 ppm ofVC, 55 ppm
of VDC, or uncontaminated air for 6 hr/day and 5
days/week. All animals lived in the same stainless
steel cages with wire bottoms during exposure and
outside of the chambers. Mice were housed four to
six per cage and rats two per cage. Pulverized or
block laboratory chow (Wayne Manufacturing
Company) was provided at all times except during
exposure. Water was available ad libitum. A 12-hr
light cycle was maintained at all times. The temper-
ature in the chamber and in the room averaged 24 +
1,3°C. The relative humidity ranged 25-60o at the
start ofthe experiment and was later regulated at 50
± l0o. Four animals of each species, sex, and ex-
posure level were terminated for various laboratory
tests, gross and histopathologic examinations at the
end of 1, 2, 3, 6, and 9 months; the surviving ani-
mals were terminated at the end of 12 months.
Laboratory Evaluations
All animals were observed throughout the study
for adverse signs. Feed consumption was recorded
weekly and body weight biweekly at a uniform
time of day. Heart (mouse) or aortic (rat) blood
from four males and four females of each group of
each species was collected under anesthesia (ether
for mice and sodium pentobarbital for rats) at in-
terim and final terminations. Hematology (RBC, re-
ticulocyte, platelet, WBC and differential counts,
nucleated RBC, hematocrit, hemoglobin,
methemoglobin, and Heinz bodies) and clinical
blood chemistry (SGPT and BUN) were performed
on all samples. For rats, prothrombin time, SGOT,
alkaline phosphatase, bilirubin, creatinine, LDH,
a-HBDH, immunoglobin IgA, IgB-A, IgB-B, and
IgM (14), total protein (15), albumin (16), globulin
(by difference), and collagen contents in liver and
lung (17, 18) were also measured. Macrophage
counts of pulmonary washings and cytogenic
analysis of bone marrow cultures (19) were per-
formed on the control, and animals receiving 1000
ppm VC and 55 ppm VDC animals. Limbs from the
longest exposed animals were examined for os-
teoporosis or malacia using a senograph x-ray
machine. They were examined for the presence of
any bone tumors, any changes in bone density, cor-
tical thickness or striations within the bone cortex,
any loss ofbone cortex, or any unusually trabecular
pattern ofthe bone. Other specific studies including
14C-thymidine incorporation into DNA (20), he-
patic aminolevulinic acid (ALA) synthetase (21),
urinary ALA assays (22) and a-fetoprotein (23)
were performed in mice and /or rats.
When moribund or at termination, all animals
were euthanized for necropsy after the collection of
blood. Gross examination, especially for any ap-
pearance of abnormal growth or other lesions, was
carefully performed on all tissues including the
brain, pituitary, thyroids, respiratory tract, alimen-
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pancreas, spleen, mesenteric lymph nodes, and
body cavities. The brain, liver, kidneys, spleen and
gonads were removed and weighed. Tumors with
adjacent normal tissues and the whole orportions of
the various tissues were fixed, processed, sec-
tioned, and stained for microscopic examination.
All external and internal tumors were carefully ex-
amined and identified histologically.
Results
Mice
General Observations. There were five early
deaths, apparently due to the acute effect ofthe test
compounds. Two males and one female exposed to
the highest level of VC were found dead between
the third and ninth days of exposure; two males
exposed to VDC died on the 13th day. They were
replaced with healthy mice from the same shipment
for the remainder ofthe experiment. Thereafter, all
mice appeared in good health.
During the sixth month, afew mice exposed to VC
diedorwereterminated beforetheirimminentdeath.
The clinical signs included rough hair coat,
lethargy, anorexia and rapid weight loss. No death
occurred in the control group or the group exposed
to VDC. During the seventh through the ninth
months, the general health of the mice exposed to
VC deteriorated. Additional clinical signs were ab-
dominal distention and/or the appearance of exter-
nal tumor masses, especially mammary gland
tumors in the females. As shown in Table 1, there
were numerous deaths or unscheduled termina-
Table 1. Number of deaths and unscheduled terminations of mice
exposed to VC or VDC.
Deaths or terminations
during exposure month
Treatment Sex 6 7 8 9 10 11 12
Control M 1 1
F
VC, 50 ppm M 1 1 1 1 1 1
F 1 2 4 4 2 1
VC, 250 ppm M 1 4 2 1 - 1
F 3 4 10 - - -
VC, 1000 ppm M 2 3 5 3 - -
F 2 9 6 4
VC, 55 ppm M --- 2
F.1
tions, proportional to exposure levels ofVC. By the
end ofthe ninth month, all males and females in the
group exposed to 1000 ppm and all females exposed
to 250 ppm died or were terminated. Additional
mice exposed to 250 or 50 ppm died or were termi-
nated during the 10th through 12th months. In the
control group, two males died during the eighth and
ninth months. One death was due to injury from
fighting, the other mouse was found dead with au-
tolysis and the cause ofdeath was unknown. Of the
mice exposed to 55 ppm of VDC, two males were
terminated during the ninth month and one female
during the 10th month. They all had tumors in the
liver.
Body Weight. The weight gains ofthe male and
female mice exposed to 1000 ppm of VC or 55 ppm
ofVDC were comparable to those ofthe respective
controls during the first 8 months (Fig. 1). Although
not shown, the body weights ofthe mice exposed to
50 or 250 ppm of VC were also not significantly
different from the controls. During the ninth month,
the body weights ofboth the males and the females
exposed to 1000 ppm began to decline, followed by
sudden death.
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FIGURE 1. Body weights ofmale and female mice exposed to VC
or VDC: (.) control; (A) 1000 ppm VC; (o) 55 ppm VDC.
Laboratory Tests. No persistent change was
found in the following laboratory results ofthe male
and female mice exposed to VC or VDC as com-
pared with those of the respective controls:
hematology, clinical blood chemistry, cytogenic
December 1977analysis of bone marrow cultures, x-ray examina-
tions of extremities, and serum a-fetoprotein.
However, the pulmonary macrophage count in the
male mice exposed to 1000 ppm of VC, but not at
lower levels, was greater than that of the control
mice at the end ofthe ninth month. The only female
mouse in the 250 or 1000 ppm ofVC group that was
examined at the end ofthe ninth month also had an
elevation of pulmonary macrophage count. At the
12th month, one of two males exposed to 50 ppm
also had an elevated macrophage count. There was
no survival in the group exposed to 250 or 1000
ppm. The mice with elevated macrophage count
also had bronchiolo-alveolar adenoma.
A study of DNA synthesis was undertaken to
determine ifthe observation ofan increased number
ofmitotic figures in the liver ofa few mice exposed
to VC or VDC could be confirmed at the biochemi-
cal level. DNA synthesis, as measured by
14C-thymidine incorporation into DNA, was sig-
nificantly increased in the livers of male mice ex-
posed to 50 ppm of VC for 11 months (Table 2).
However, the livers ofthese mice did not show any
increase in the number of mitotic figures or any
evidence of neo- or preneoplastic lesions.
Table 2. 14C-Thymidine Incorporation into Hepatic DNA of male
mice exposed to VC for 11 months.
VC level, ppm
0
50
14C activity,
dpm mg DNAa
2886 ± 240(8)
4232 ± 463(7)b
'Mean ± SE (number of observations).
bSignificantly different from the control [two-sample rank test
(24)].
Lesions in Early Deaths. Microscopic exami-
nation of the five unscheduled deaths (two males
and one female exposed to 1000 ppm ofVC for 3 to
9 days, and two males exposed to 55 ppm of VDC
for 13 days) revealed a number of lesions. These
included an acute toxic hepatitis, characterized by
focal to marked congestion, and marked diffused
coagulation type necrosis ofhepatocytes beginning
in the centrilobular area. Marked tubular necrosis
cha:acterized by pyknosis and eosinophilic granula-
tion of the cytoplasma in the renal cortex was also
observed.
Lesions in Late Death. During the eighth to
ninth months of exposure, several mitotic figures
were observed in the liver of a number of mice ex-
posed to 50 or 1000 ppm of VC. This observation
was not apparent in mice terminated at other times.
Mice exposed to VDC for 6 to 12 months had sev-
eral changes in the liver. There were enlarged and
basophilic hepatocytes with enlarged nuclei, many
of which had large round eosinophilic inclusions;
mitotic figures or polyploidy; microfoci of
mononuclear cells; focal degeneration and necrosis.
The incidence and severity of these lesions pro-
gressed with the lengths ofexposure. Some ofthese
mice also had hemangiosarcoma.
Tumors. Nearly all the mice that died or were
terminated ahead of schedule and many mice that
were terminated on schedule at various times de-
veloped one or more types of tumors. Bronchiolo-
alveolar adenoma first occurred in mice exposed to
1000 or 250 ppm of VC during the second month.
The adenoma was characterized by papillary prolif-
eration of alveolar epithelium forming small and
well-demarcated, but not capsulated, round
nodules. The incidence (Fig. 2) and severity of this
tumor increased in direct proportion to the level of
VC and to the length ofexposure. Only one control
male mouse had a bronchiolo-alveolar adenoma
during the ninth month. A few small nodules of
bronchiolo-alveolar adenoma occurred in six mice
exposed to 55 ppm of VDC.
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FIGURE 2. Incidence ofbronchiolo-alveolar adenoma in male and
female mice exposed to VC or VDC: (-) 1000 ppm VC: (A)
250ppm VC;(0)50ppm VC;(V) 55 ppm VDC; (o)controls.
Hemangiosarcoma occurred in the livers of mice
exposed to 1000 or 250 ppm ofVC starting the sixth
month. The hemangiosarcoma was characterized
by moderate to severe proliferation of endothelial
cells lining the sinusoids, dilation of the sinusoids,
focal hemorrhage forming small to large cavernous
blood spaces, invasion of the hepatic parenchyma
with neoplastic cells, and mild to severe necrosis.
In addition, hemangiosarcoma was occasionally
found in other tissues including mammary gland,
Environmental Health Perspectives 28heart, gastrointestinal tract, pancreas, kidney,
epididymis, testis, mesenteric lymph nodes and
skeletal muscle. The incidence and severity of the
hemangiosarcoma in the liver and the overall inci-
dence in other tissues were related to the level of
VC and the length of exposure (Fig. 3). Hepatic
hemangiosarcoma occurred in three mice exposed
to 55 ppm of VDC. This tumor was not found in
any control mice. There were also hemangiomas in
the mediastinum of one female exposed to 50 ppm
of VC and in the connective tissue adjacent to the
salivary gland of one male exposed to 1000 ppm.
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found in any control mice or mice exposed to 55
ppm of VDC. Three mice exposed to VDC de-
veloped hepatoma. Hepatic cell carcinoma, renal
adenoma, or skin keratoacanthoma, was observed
in one ortwo mice exposed to50 or 1000 ppm ofVC
or 55 ppm ofVDC.
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FIGURE 3. Incidence of hemangiosarcoma in male and female
mice exposed to VC or VDC: (.) 1000 ppm VC; (A) 250 ppm
VC; (o) 50 ppm VC; (o) 55 ppm VDC; ( ) liver; (--) other
organs.
The third major type of tumor was found in the
mammary gland of the females. Mammary gland
tumors started to occur during the sixth or seventh
month. The incidence increased with increases in
VC levels and/or length ofexposure (Fig. 4). These
tumors were composed of ductular adenocar-
cinoma, squamous cell carcinoma, and/or anaplas-
tic cell carcinoma. The severity ofthese tumors in-
creased in mice exposed to higher levels ofVC and
in mice that died or terminated at later dates. In
addition, the squamous and/or anaplastic cell car-
cinomas metastasized to the lungs of a number of
mice. This type of tumor was not seen in any con-
trol mice ormice exposed to 55 ppm ofVDC.
Malignant lymphoma was seen in one female ex-
posed to 50 ppm and one male exposed to 1000 ppm
during the sixth month, in two females exposed to
250 ppm during the ninth month, and in one male
and three females exposed to 1000 ppm during the
ninth month. The malignant lymphomas involved
the spleen, liver, lung, kidney, heart, subcutaneous
tissue, and/or mammary gland. This tumor was not
FIGURE 4. Incidence of mammary gland tumors and metastases
in the lung in female mice exposed to VC: (.) 1000 ppm; (A)
250 ppm; (o) 50 ppm; (-) mammary gland tumor; (--)
metastasis to lung.
Rats
General Observations. No remarkable ad-
verse signs were seen in any rats during the first 7
months. Thereafter, a number of rats died or were
terminated before their imminent death. In the
group exposed to 1000 ppm ofVC, eight males and
13 females died or were terminated during the
eighth through the 12th months. In the group ex-
posed to 250 ppm, four males and 10 females died or
were terminated during the same period. Two
females exposed to 50 ppm died. No death occurred
in the control group. One female rat exposed to 55
ppm of VDC was terminated. Before death, these
rats had rough hair coat, lost muscular tone, were
lethargic and lost weight.
Body Weight. The body weights of the female
rats exposed to 1000 ppm ofVC or 55 ppm ofVDC
were generally less than that ofthe female controls
afterthe 4th week and those ofthe males exposed to
55 ppm ofVDC were generally less than that ofthe
male controls afterthe 24th week (Fig. 5). The body
weights ofthe male andfemale rats exposed to 50 or
250 ppm of VC, although not shown in Figure 5,
were comparable tothe controls.
December 1977 29ney; squamous cell carcinoma, keratoacanthoma or
fibroma in the skin; adenocarcinoma in the seba-
ceous gland; and chromophobe cell adenoma in the
pituitary. These occasional tumors were not related
to VC or VDC.
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FIGURE 5. Body weights of male and female rats exposed to VC
or VDC: (-) control; (A) 1000 ppm VC; (o) 55 ppm VDC.
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Laboratory Tests. No persistent change was
found in the following laboratory results ofthe male
and female rats exposed to VC or VDC as com-
pared with those of the respective controls:
hematology, clinical blood chemistry, pulmonary
macrophage count, cytogenic analysis ofbone mar-
row culture, x-ray examinatior. of extremities, col-
lagen contents in liver and lung, serum ALA syn-
thetase, urinary ALA level, and serum
a-fetoprotein.
Tumors. Hepatic and/or pulmonary hemangio-
sarcoma occurred in rats exposed to 250 or 1000
ppm of VC during the ninth through the 12th
months; the incidence increased with increases in
VC levels and length of exposure (Fig. 6). Most of
these rats died or were terminated ahead of
schedule. The rats with hepatic hemangiosarcoma
usually developed pulmonary hemangiosarcoma. In
addition, hemangiosarcoma occasionally occurred
in other tissues including omentum, mesentery, or
subcutaneous tissue of rats exposed to 50, 250, or
1000 ppm of VC. Two rats exposed to 55 ppm of
VDC developed hemangiosarcoma in the mesen-
teric lymph node or subcutaneous tissue. Heman-
giosarcoma was not found in the liver, lung or any
other organs of any control rats.
A few other tumors occasionally occurred in one
or several rats. The tumors included a small nodule
of bronchiolo-alveolar adenoma; reticulo-en-
dothelial cell carcinoma or hepatoma in the liver;
ductular adenocarcinoma or fibroadenoma in the
mammary gland ofthe female; malignant lymphoma
in the spleen or other organs; adenoma in the kid-
FIGURE 6. Incidence of hemangiosarcoma in male and female
rats exposed to VC: (.) 1000 ppm; (A) 250 ppm; ( ) liver;
(--) lung.
Other Microscopic Changes. A mild to mark-
edly severe focal, disseminated vacuolization,
probably fatty change, was observed in livers of
most of the rats treated with VDC. A few controls
and a few rats treated with VC showed this change
but to a milder degree.
Discussion and Conclusions
Mice
Exposure to VC or VDC caused some early
deaths. Among a total of 36 mice of each sex, two
males and one female exposed to 1000 ppm of VC
died between the third and ninth days, and two
males exposed to 55 ppm of VDC died on the 13th
day. Histopathology revealed acute toxic hepatitis
and marked tubular necrosis of the renal cortex.
Thereafter, all mice appeared in good health. Dur-
ing the sixth month, a few mice exposed to various
concentrations of VC had rough hair coat, became
lethargic, and lost weight quickly. They died or
were terminated before their imminent death. After
the seventh month, the general health of the mice
exposed to VC deteriorated. A large number of
mice had abdominal distention and external tumor
masses, especially mammary gland tumors in the
females. By the ninth month, both the male and
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30female mice exposed to 1000 ppm of VC and all
females exposed to 250 ppm died or were termi-
nated. Only a few mice exposed to 50 ppm survived
for 12 months. Two male control mice and two
males and one female exposed to 55 ppm of VDC
died during the experiment.
Pulmonary macrophage count was elevated in
some mice exposed to VC. The macrophage count
was elevated earlier in mice exposed to 1000 or 250
ppm than in mice exposed to 50 ppm. The mice with
elevated macrophage count also had bronchiolo-
alveolar adenoma. However, not all mice with
bronchiolo-alveolar adenoma had the elevation of
macrophage count. The relationship ofmacrophage
count and this pulmonary tumor needs further in-
vestigation.
A moderate number of mitotic figures were ob-
served in the liver ofmice exposed to VC during the
ninth month. DNA synthesis, as measured by
'4C-thymidine incorporation into DNA, was sig-
nificantly increased in the livers of male mice ex-
posed to 50 ppm of VC for 11 months. However,
the mitotic figures were not observed in the livers of
these mice, nor was there any evidence ofneoplas-
tic and preneoplastic lesions. Further studies are
underway to determine if the histopathological ob-
servation could be related to changes at the
biochemical level.
A number oflesions occurred in the liver ofmice
exposed to 55 ppm of VDC. The lesions included
-enlarged and basophilic hepatocytes, enlarged nu-
clei with eosinophilic inclusions, mitotic figures or
polyploidy, microfoci of mononuclear cells, focal
degeneration, and necrosis. The significance of
these lesions as related to the hemangiosarcoma or
other liver tumors may be of a "preneoplastic" na-
ture. Since only a few mice, as compared to the
number of those with these preneoplastic lesions,
developed the definite neoplasms, further study
with mice exposed to high levels of VDC is needed
to establish any definite conclusions.
Exposure to 50, 250 or 1000 ppm of VC, 6 hr/day
and 5 days/week, caused bronchiolo-alveolar
adenomas, mammary gland tumors, and heman-
giosarcomas. The squamous and anaplastic cell
carcinomas of the mammary gland metastasized to
the lung. Hemangiosarcomas first occurred in the
liver and then in other organs. The incidence of
these tumors quickly increased, especially in mice
exposed to 1000 or 250 ppm. The severity was in
direct proportion to the levels of VC and the length
ofexposure. In addition, a few mice exposed to VC
also developed malignant lymphomas. Bron-
chioloalveolar adenomas and hepatic hemangiosar-
comas also occurred in some mice exposed to 55
ppm of VDC. The pathogenesis of these tumors
was described elsewhere (25).
Rats
Rats were more resistant to the toxic and car-
cinogenic effects of VC or VDC. Exposure to 50,
250, or 1000 ppm of VC or 55 ppm of VDC did not
cause any acute deaths, or any persistant changes in
hematology or clinical laboratory results. However,
exposure to 1000 ppm of VC or 55 ppm of VDC
slightly depressed the body weight ofthe females or
both sexes. In addition, a number of deaths oc-
curred in the rats exposed to 250 or 1000 ppm ofVC
or 55 ppm of VDC starting the 9th month.
Exposure to 250 or 1000 ppm of VC caused
hemangiosarcoma in the liver starting the ninth
month. In contrast to the mice, many of the rats
with hepatic hemangiosarcomas also developed
hemangiosarcomas in the lung. Two rats exposed to
55 ppm of VDC developed hemangiosarcomas in
the mesenteric lymph node or subcutaneous tissue.
The livers of most rats exposed to VDC had a mild
or markedly severe focal, disseminated vacuoliza-
tion, probably fatty change. The significance ofthis
change as related to the exposure of VDC is not
understood.
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